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The Oslo Balloon Angioplasty versus Conservative Treatment Study
(OBACT)
The 2-years Results of a Single Centre, Prospective, Randomised Study
in Patients with Intermittent Claudication
Nylænde M., Abdelnoor M., Stranden E., Morken B., Sandbæk G., Risum
Ø., Jørgensen J.J., Lindahl A.K., Arnesen H., Seljeflot I., Kroese A.J. Eur J
Vasc Endovasc Surg 2006;33:2-11.
Objectives To compare the effect of optimal medical treatment only
(OMT) with OMT combined with percutaneous transluminal angioplasty
(OMTPTA) in patients with intermittent claudication (IC).
Design A single centre prospective, randomised study. Quality of life
(QoL) was the primary outcome measure. Secondary measures were ankle-
brachial-index (ABI), treadmill walking distances and mortality.
Methods From a total of 434 patients considered for inclusion into the
trial, only 56 patients with disabling IC fulfilled the inclusion criteria. The
patients were randomised into treatment groups consisting of 28 patients
each and followed for 2 years. ABI and treadmill walking distances were
measured in addition to the visual analogue scale (VAS) for pain evaluation,
and QoL assessment using the Short Form (SF-36 and Claudication Scale
(CLAU-S).
Results The demographic data in the 2 groups were almost identical.
After 2 years of follow-up the ABI, the treadmill walking distances and the
VAS were significant improved in the group treated with OMTPTA,
compared to the group treated with OMT only (p0.01 for all). Further-
more, some variables from the QoL assessment also showed a significant
improvement in favour of the OMTPTA group (p0.05 for all).
Conclusion The advantage of conducting a single centre study and
adhering to very strict inclusion criteria was illustrated by the homogenous
demographic data of the two groups. This partly outweighed the disadvan-
tage of having included a relatively small number of patients. Early interven-
tion with PTA in addition to OMT seems to have a generally more positive
effect compared to OMT only, on haemodynamic, functional as well as QoL
aspects during the first 2 years in patients with IC.
Autologous Blood Vessels Engineered from Peripheral Blood Sample
Aper T., Schmidt A., Duchrow M., Bruch H.-P. Eur J Vasc Endovasc Surg
2006;33:32-38.
Objective Although many efforts have been made to generate small-
diameter (5 mm) vascular grafts by means of tissue engineering, improvement
in patency and functionality still remains a great challenge. It is our hypothesis
that to achieve long-term functionality and patency, not only the complete
lining with endothelial cells but also full biocompatibility is essential.
Design The aim was the development of a conduit from a scaffold and
endothelial progenitor cells (EPC) separated from peripheral blood of a
single donor.
Materials and methods EPC and a fibrin preparation were separated
from porcine peripheral blood. Fibrin segments were generated seeded with
EPC and were perfused in a bioreactor in vitro.
Results From 100 ml blood 12–15 cm long fibrin tubes were success-
fully generated lined with endothelial-like cells. Seeded tubes showed a
remarkable elasticity and burst strength up to 90 mm mercury.
Conclusions Stable fibrin tubes were successfully generated com-
pletely lined with an endothelium-like monolayer from fibrin and EPC, both
isolated from the same volume of blood. Although their stability is not those
needed for arterial grafting, our results raise the hope, that with distinct
improvements in future studies functional autologous vascular grafts could
be engineered from the patient’s own blood.
The Superficial Cervical Plexus Block for Postoperative Pain Therapy
in Carotid Artery Surgery. A Prospective Randomised Controlled Trial
Messner M., Albrecht S., Lang W., Sittl R., Dinkel M. Eur J Vasc Endovasc
Surg 2006;33:49-53.
Objectives Rapid and reliable neurological evaluation soon after ca-
rotid artery surgery is feasible with modern methods of general anesthesia,
but postoperative pain therapy remains a challenge. Use of opioids can mask
neurological deficits. We investigated whether superficial cervical plexus
block reduced postoperative opioid consumption after carotid endarterec-
tomy.
Design Prospective, randomised, double-blinded, placebo controlled
trial.
Methods 46 patients undergoing unilateral carotid endarterectomy
under general anesthesia were randomized to either superficial cervical block
with ropivacaine (n23) or placebo (n23). A patient controlled analgesia
device (PCA) delivering morphine was provided for all patients. Subjective
pain levels (visual analog scale, VAS) were recorded. The primary outcome
was total morphine consumption on discharge from the recovery room.
Secondary outcomes included arterial pCO2 (as an indicator of central
nervous effects of morphine) and patient satisfaction.
Results No adverse effects of the superficial cervical plexus block were
reported. Four patients in the placebo group were excluded because of other
drug use post-operatively. Per protocol analysis compared 23 patients in
ropivacaine group and 19 patients in the placebo group. The ropivacaine
group had a significant reduction in morphine consumption (3.82.0
versus 12.94.0, p0.001), lower maximal pain scores (2.62.0 versus
5.81.6, p0.001), and paCO2 levels (39.02.6 versus 41.93.4,
p0.008) at discharge from the recovery room. Patient satisfaction (1very
good to 6insufficient) was substantially higher in the ropivacaine group
(1.70.7 versus 3.11.2, p00.01).
Conclusion The significant and clinically relevant lower morphine
consumption and pain score, as well as the substantially higher patient
satisfaction demonstrate that superficial cervical plexus block provides effec-
tive pain relief for patients undergoing carotid endarterectomy.
Increased Endothelial Cell Apoptosis in Symptomatic High-grade Ca-
rotid Artery Stenosis: Preliminary Data
Trostdorf F., Landgraf C., Kablau M., Schmitz-Rixen T., Sitzer M. Eur J
Vasc Endovasc Surg 2006;33:64-67.
Objective Endothelial cell (EC) apoptosis has been associated with
thrombus formation on an eroded atherosclerotic plaque surface. Alongside
plaque rupture, it may constitute another mechanism of plaque destabilisa-
tion. We investigated whether EC apoptosis also may be involved in plaque
destabilisation in high-grade internal carotid artery (ICA) stenosis.
Methods We compared the degree of EC apoptosis in carotid endar-
terectomy specimens from n38 patients undergoing surgery for high-
grade ICA stenosis (70%; n19 clinically asymptomatic; n19 symptom-
atic). The total number of endothelial cells (ECs) and apoptotic cells were
determined using CD31 immunohistochemistry and the TdT dUTP nick
end-labeling (TUNEL) method respectively.
Results Overall, EC apoptosis was a rare finding. The median percent-
age of apoptotic ECs was 0.0% (0.0–0.7%) in asymptomatic and 0.5%
(0.0–7.3%) in symptomatic plaques (p0.015, Mann-Whitney U test). No
difference was observed between ruptured and unruptured plaque (0.0%
[0.0–6.0%] vs 0.0% [0.0–5.7%]; p0.446).
Conclusions Our results indicate that TUNEL-detected EC apoptosis
is rare in carotid plaque from patients with 70% stenosis.
Hybrid-procedures for the Treatment of Thoracoabdominal Aortic
Aneurysms and Dissections
Gawenda M., Aleksic M., Heckenkamp J., Reichert V., Gossmann A.,
Brunkwall J. Eur J Vasc Endovasc Surg 2006;33:70-76.
Aim The conventional open repair of thoracoabdominal aneurysms
and dissections remains complex and demanding and is associated with
significant morbidity and mortality. We present our experience of hybrid
open and endovascular treatment of thoracoabdominal aneurysms and dis-
sections.
MethodsWithin an experience of 226 aortic stent-grafts between 1998
and April 2006, 6 of the patients (median age 60 years, range 35 to 68 years)
with thoracoabdominal aneurysms (Crawford type I, II, III, and V) were
treated with a combined endovascular and open surgical approach. Five men
and one woman, with median aneurysm diameter of 75 mm (range 70–
100 mm), received revascularization of the renal arteries, the superior mes-
enteric artery, and the coeliac trunk accomplished via transperitoneal bypass
grafting. Aneurysmal exclusion was then performed by stent-graft deploy-
ment.
Results The entire procedure was technically successful in all patients.
The patients were discharged a median of 9 days after the operation, while
the postoperative studies revealed the patency of the vessels and no evidence
of type I endoleak or secondary rupture of the aneurysm. During follow up
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(1 to 22 months) spiral-CT scanning revealed distinct shrinkage of the
aneurysm, no graft migration or endoleak and patency of all revascularised
vessels, except one renal artery in two patients. No patient experienced any
temporary or permanent neurological deficit, and no dialysis was necessary.
ConclusionThe combined endovascular and open surgical approach is
feasible, without cross clamping of the aorta and with minimized ischemia
time for renal and visceral arteries, and seems to be an appropriate strategy
for patients with a thoraco-abdominal aortic aneurysm or dissection.
Fenestrated and Branched Stent-grafting After Previous Surgery Pro-
vides a Good Alternative to Open Redo Surgery
Verhoeven E.L.G., Muhs B.E., Zeebregts C.J.A.M., Tielliu I.F.J., Prins
T.R., Bos W.T.G.J., Oranen B.I., Moll F.L., van den Dungen J.J.A.M. Eur
J Vasc Endovasc Surg 2006;33:83-89.
Objective To present our experience using fenestrated and branched
endoluminal grafts for Para-anastomotic aneurysms (PAA) following prior
open aneurysm surgery, and after previous endovascular aneurysm repair
(EVAR) complicated by proximal type I endoleak.
Methods Fenestrated and/or branched EVAR was performed on
eleven patients. Indications included proximal type I endoleak after EVAR
and short infrarenal neck (n4), suprarenal aneurysm after open AAA
(n4), distal type I endoleak after endovascular TAA (n1), proximal
anastomotic aneurysm after open AAA (n1), and an aborted open AAA
repair due to bleeding around a short infrarenal neck.
ResultsThe operative target vessel success rate was 100% (28/28) with
aneurysm exclusion in all patients. Mean hospital stay was 6.0 days (range
2–12 days, SD 3.5 days). Thirty day mortality was 0%. All cause mortality
during 18 months mean follow-up (range 5–44 months, SD 16.7 months)
was 18% (2/11) with no deaths from aneurysm rupture. Cumulative visceral
branch patency was 96% (27/28) at 42 months. Average renal function
remained unchanged during the follow-up period.
Conclusions Our report highlights the potential of fenestrated and
branched technology to improve re-operative aortic surgical outcomes. The
unique difficulties of increased graft on graft friction hindering placement,
short working distance, and increased patient co-morbidities should be
recognized.
Medical Optimisation Can ReduceMorbidity andMortality Associated
with Elective Aortic Aneurysm Repair
Dawson J., Vig S., Choke E., Blundell J., Horne G., Downham C., Loftus I.,
Thompson M.M. Eur J Vasc Endovasc Surg 2006;33:99-103.
Objectives Patients with aortic aneurysms have significant comorbidi-
ties which influence outcome. Our practice includes comprehensive assess-
ment to identify comorbidities, allowing subsequent medical optimisation
prior to aneurysm repair. The aim of this study was to assess this process and
to identify any factors predictive of outcome.
Design Prospective observational study.
Materials Medical case notes of 200 patients referred with aortic
pathology.
Methods Data analysed included preoperative, perioperative and post-
operative factors. Multiple logistic regression analysis was performed to
identify predictors of outcome.
Results Following assessment 17 patients (8.5%) were found to be
unfit for intervention and 165 patients (82.5%) proceeded to aneurysm
repair. In this group assessment uncovered previously undiagnosed car-
diac, respiratory and renal comorbidity in 19%, 57% and 29% of patients
respectively. Multiple logistic regression analysis indicated that optimi-
sation by a renal physician reduced post-operative renal impairment (OR
0.12, 95% CI 0.03–0.45, P0.002) while optimisation by a cardiologist
reduced respiratory complications (OR 0.7, 95% CI 0.05–0.99,
P0.049). An abnormal echocardiogram was associated with pneumonia
(OR 6.9, 95% CI 1.6–29, P0.01) and death (OR 7.9, 95% CI 1.15–54,
P0.036).
Conclusion Pre-operative assessment identifies previously un-
diagnosed comorbidity in a significant proportion of patients. Sub-
sequent medical optimisation may reduce post-operative morbidity and
mortality.
Outcome of Ultrasound-guided Sclerotherapy for Varicose Veins: Me-
dium-term Results Assessed by Ultrasound Surveillance
Myers K.A., Jolley D., Clough A., Kirwan J. Eur J Vasc Endovasc Surg
2006;33:115-120.
Objective To estimate medium-term success after a technique for
ultrasound-guided sclerotherapy for superficial chronic venous disease.
DesignA prospective study in a single unit with ultrasound surveillance
after treatment.
Materials Results after 1189 treatment sessions for 807 venous saphe-
nous veins and related tributaries or non-saphenous tributaries in 489
patients.
Methods Univariate life table analysis determined primary and second-
ary success rates. Multivariate Cox regression analysis detected covariates
that affected outcome.
Results Primary and secondary success rates at 36 months for all veins
were 52.4% (95%CI 46–58%) and 76.8% (95%CI 71–82%). Cox regression
analysis for primary success for all veins showed significantly worse results for
saphenous veins compared to tributaries (HR 3.72 – 95%CI 1.9 to 7.3). Cox
regression for all saphenous veins showed independently worse results for
patients less than 40 years age (HR 2.16 – 95%CI 1.27–3.66), small
compared to great saphenous veins (HR 1.58 – 95%CI 1.11–2.24), veins
greater than 6mm diameter compared to smaller veins (HR 2.22 – 95%CI
1.40–3.50), liquid compared to foam sclerotherapy (HR 2.20 – 95%CI
1.28–3.78), lower volumes of sclerosant compared to volumes greater than
12 ml (HR 0.51 – 95%CI 0.33–0.81) and highly diluted compared to
concentrated sclerosant (HR 2.05 – 95%CI 1.21–3.46) with worse results
using highly diluted or undiluted 3% sclerosant compared to a 1.5% concen-
tration. There were no significant differences for primary success for saphe-
nous veins for date of procedure, sex, side, primary or recurrent varicose
veins, or commercial type of sclerosant.
Conclusions Ultrasound-guided sclerotherapy gives satisfactory re-
sults if it is accepted that treatment may need to be repeated to achieve
secondary success. Results provide a basis for further research to explore
factors that might affect outcome. Younger patients with larger diameter
saphenous veins may warrant alternative forms of treatment, particularly for
small saphenous reflux.
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